Hengtong Han
机构：Shandong University of Technology, First Hospital of Lanzhou University, Lanzhou University · ORCID：0000-0001-7671-944X
发表论文 20 篇 · 总被引 185 次 · h-index 6
代表论文
- Stem cell therapy in liver regeneration: Focus on mesenchymal stem cells and induced pluripotent stem cells (2021 · Pharmacology & Therapeutics · 被引 91)
- Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injury (2019 · International Immunopharmacology · 被引 31)
- Mesenchymal stem cells-based therapy in liver diseases (2022 · Molecular Biomedicine · 被引 24)
- Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer (2024 · International Immunopharmacology · 被引 14)
- Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodeling (2025 · Molecular Cancer · 被引 11)
- The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment (2025 · Biomolecules · 被引 6)